Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
medical device
9
×
national blog main
9
×
raleigh-durham blog main
raleigh-durham top stories
9
×
san francisco blog main
san francisco top stories
clinical trials
national
national top stories
boston blog main
boston top stories
new york blog main
new york top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
amgen
eli lilly
startups
abbvie
bristol-myers squibb
cancer drugs
cancer immunotherapy
deals
glaxosmithkline
What
companies
drug
roundup
bio
fda
ipo
biotech
cancer
cash
company
disease
drugs
firms
hasn’t
life
migraine
nash
new
news
public
science
sciences
week
according
acquisitions
activity
akcea
appetite
approval
approved
arguments
big
biggest
biotechs
black
blood
bread
broader
build
butter
Language
unset
Current search:
" national blog main "
×
" medical device "
×
" raleigh-durham top stories "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M